Microstructure, pathophysiology, and potential therapeutics of COVID‐19: a comprehensive review
There have been over seven million cases and almost 413 372 deaths globally due to the
novel coronavirus (2019‐nCoV) associated disease COVID‐19, as of 11 June 2020 …
novel coronavirus (2019‐nCoV) associated disease COVID‐19, as of 11 June 2020 …
The human coronavirus disease COVID-19: its origin, characteristics, and insights into potential drugs and its mechanisms
The emerging coronavirus disease (COVID-19) swept across the world, affecting more than
200 countries and territories. Genomic analysis suggests that the COVID-19 virus originated …
200 countries and territories. Genomic analysis suggests that the COVID-19 virus originated …
A comprehensive SARS-CoV-2 and COVID-19 review, Part 1: Intracellular overdrive for SARS-CoV-2 infection
DA Jamison Jr, S Anand Narayanan… - European Journal of …, 2022 - nature.com
COVID-19, the disease caused by SARS-CoV-2, has claimed approximately 5 million lives
and 257 million cases reported globally. This virus and disease have significantly affected …
and 257 million cases reported globally. This virus and disease have significantly affected …
Approaches towards fighting the COVID‑19 pandemic
Abstract The coronavirus disease 2019 (COVID‑19) outbreak, which has caused> 46
millions confirmed infections and> 1.2 million coronavirus related deaths, is one of the most …
millions confirmed infections and> 1.2 million coronavirus related deaths, is one of the most …
Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective
C Lee, WJ Choi - Archives of pharmacal research, 2021 - Springer
The novel beta coronavirus (SARS-CoV-2, designated as COVID-19) that is responsible for
severe acute respiratory syndrome has devastated the global economy and health care …
severe acute respiratory syndrome has devastated the global economy and health care …
Potential drug targets of SARS-CoV-2: From genomics to therapeutics
The emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) from
China has become a global threat due to the continuous rise in cases of Coronavirus …
China has become a global threat due to the continuous rise in cases of Coronavirus …
The novel insight of SARS-CoV-2 molecular biology and pathogenesis and therapeutic options
On December 31, 2019, a novel coronavirus, being the third highly infective CoV and named
as coronavirus disease 2019 (COVID-19) in the city of Wuhan, was announced by the World …
as coronavirus disease 2019 (COVID-19) in the city of Wuhan, was announced by the World …
The pathogenesis of coronavirus-19 disease
AC Borczuk, RK Yantiss - Journal of biomedical science, 2022 - Springer
Severe acute respiratory syndrome-associated coronavirus-2 (SARS-CoV-2) is the causal
agent of coronavirus disease-2019 (COVID-19), a systemic illness characterized by variably …
agent of coronavirus disease-2019 (COVID-19), a systemic illness characterized by variably …
Animal models of mechanisms of SARS‐CoV‐2 infection and COVID‐19 pathology
SJ Cleary, SC Pitchford, RT Amison… - British journal of …, 2020 - Wiley Online Library
The coronavirus disease 2019 (COVID‐19) pandemic caused by SARS‐CoV‐2 infections
has led to a substantial unmet need for treatments, many of which will require testing in …
has led to a substantial unmet need for treatments, many of which will require testing in …
The COVID-19 pandemic: a comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control
A pneumonia outbreak with unknown etiology was reported in Wuhan, Hubei province,
China, in December 2019, associated with the Huanan Seafood Wholesale Market. The …
China, in December 2019, associated with the Huanan Seafood Wholesale Market. The …